Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -162,451 | -129,474 | -96,655 | -104,787 | -71,096 |
| Depreciation Amortization | 490 | 393 | 377 | 357 | 439 |
| Accounts payable and accrued liabilities | 4,598 | 2,510 | 2,324 | 351 | -683 |
| Other Working Capital | 2,775 | 9,164 | -589 | 3,022 | 2,830 |
| Other Operating Activity | 7,872 | 13,056 | 10,816 | 18,992 | 17,820 |
| Operating Cash Flow | $-146,716 | $-104,351 | $-83,727 | $-82,065 | $-50,690 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -159 | 14 | -363 | -1,575 |
| Purchase Of Investment | -500,722 | -394,959 | -255,625 | -213,660 | -486,967 |
| Sale Of Investment | 344,962 | 301,592 | 250,760 | 305,502 | 213,104 |
| Investing Cash Flow | $-155,760 | $-93,526 | $-4,851 | $91,479 | $-275,438 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 214,811 | 268,818 | 133,415 | 476 | 1,391 |
| Other Financing Activity | -6,514 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $211,297 | $268,818 | $133,415 | $476 | $1,391 |
| Beginning Cash Position | 139,480 | 68,539 | 23,702 | 13,812 | 338,549 |
| End Cash Position | 48,301 | 139,480 | 68,539 | 23,702 | 13,812 |
| Net Cash Flow | $-91,179 | $70,941 | $44,837 | $9,890 | $-324,737 |
| Free Cash Flow | |||||
| Operating Cash Flow | -146,716 | -104,351 | -83,727 | -82,065 | -50,690 |
| Capital Expenditure | N/A | -159 | N/A | -363 | -1,575 |
| Free Cash Flow | -146,716 | -104,510 | -83,727 | -82,428 | -52,265 |